Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Prognostic Significance of Peripheral Blood CD8highCD57+ Lymphocytes in Bladder Carcinoma Patients After Intravesical IL-2

DAINIUS CHARACIEJUS, VITA PAŠUKONIENĖ, JOHN J.L. JACOBS, RIMANTAS EIDUKEVIČIUS, FELIKSAS JANKEVIČIUS, NERINGA DOBROVOLSKIENĖ, MYKOLAS MAURICAS, R. JEROEN A. VAN MOORSELAAR and WILLEM DEN OTTER
Anticancer Research February 2011, 31 (2) 699-703;
DAINIUS CHARACIEJUS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dainius.characiejus{at}gmail.com
VITA PAŠUKONIENĖ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOHN J.L. JACOBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RIMANTAS EIDUKEVIČIUS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FELIKSAS JANKEVIČIUS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NERINGA DOBROVOLSKIENĖ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MYKOLAS MAURICAS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. JEROEN A. VAN MOORSELAAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WILLEM DEN OTTER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 31 no. 2 699-703
PMID 
21378359

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received December 31, 2010
  • Revision received January 25, 2011
  • Accepted January 25, 2011
  • Published online March 4, 2011.

Copyright & Usage 
Copyright© 2011 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. DAINIUS CHARACIEJUS1,2,
  2. VITA PAŠUKONIENĖ3,
  3. JOHN J.L. JACOBS4,
  4. RIMANTAS EIDUKEVIČIUS5,
  5. FELIKSAS JANKEVIČIUS1,
  6. NERINGA DOBROVOLSKIENĖ3,
  7. MYKOLAS MAURICAS2,
  8. R. JEROEN A. VAN MOORSELAAR4 and
  9. WILLEM DEN OTTER4
  1. 1Faculty of Medicine, Vilnius University, M.K.Čiurlionio 21, Vilnius, Lithuania
  2. 2Centre for Innovative Medicine, Žygimantų 9, Vilnius, Lithuania
  3. 3Institute of Oncology, Vilnius University, Santariškių 1, Vilnius, Lithuania
  4. 4VU University Medical Centre, de Boelelaan 1117, Amsterdam, the Netherlands
  5. 5Faculty of Mathematics and Informatics, Vilnius University, Naugarduko 24, Vilnius, Lithuania
  1. Correspondence to: Professor D. Characiejus, Faculty of Medicine, Vilnius University, M.K.Čiurlionio 21, LT-03101 Vilnius, Lithuania. Tel: +370 52398728, Fax: +370 52469210, e-mail: dainius.characiejus{at}gmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 19 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 31, Issue 2
February 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Significance of Peripheral Blood CD8highCD57+ Lymphocytes in Bladder Carcinoma Patients After Intravesical IL-2
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognostic Significance of Peripheral Blood CD8highCD57+ Lymphocytes in Bladder Carcinoma Patients After Intravesical IL-2
DAINIUS CHARACIEJUS, VITA PAŠUKONIENĖ, JOHN J.L. JACOBS, RIMANTAS EIDUKEVIČIUS, FELIKSAS JANKEVIČIUS, NERINGA DOBROVOLSKIENĖ, MYKOLAS MAURICAS, R. JEROEN A. VAN MOORSELAAR, WILLEM DEN OTTER
Anticancer Research Feb 2011, 31 (2) 699-703;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognostic Significance of Peripheral Blood CD8highCD57+ Lymphocytes in Bladder Carcinoma Patients After Intravesical IL-2
DAINIUS CHARACIEJUS, VITA PAŠUKONIENĖ, JOHN J.L. JACOBS, RIMANTAS EIDUKEVIČIUS, FELIKSAS JANKEVIČIUS, NERINGA DOBROVOLSKIENĖ, MYKOLAS MAURICAS, R. JEROEN A. VAN MOORSELAAR, WILLEM DEN OTTER
Anticancer Research Feb 2011, 31 (2) 699-703;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer
  • Role of Marker Lesion when Applying Intravesical Instillations of IL-2 for Non-muscle-invasive Bladder Cancer Comparison of the Therapeutic Effects in Two Pilot Studies
  • Prediction of Response in Cancer Immunotherapy
  • Google Scholar

More in this TOC Section

  • Feasibility of Minimally Invasive Surgery for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy: A Four-arm Comparative Study
  • Prior Radiotherapy Improves Progression-free Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Tremelimumab–Durvalumab
  • Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire